One of a four-membered family of transmembrane receptors, the EGF receptor (also known as ErbB1, HER1, or EGFR) is commonly overexpressed in cancer cells and is associated with a bad prognosis, just as HER2 (Nicholson et al., 2001). Here, EGFR is linked to cancer.